Literature DB >> 27844303

Acute apixaban treatment of heparin-induced thrombocytopenia.

Guillermo Delgado-García1, Roberto Monreal-Robles2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27844303     DOI： 10.1007/s11239-016-1458-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  4 in total

Review 1.  Novel oral anticoagulants for heparin-induced thrombocytopenia.

Authors:  Jessica W Skelley; Jeffrey A Kyle; Rachel A Roberts
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

2.  New oral anticoagulants in the treatment of heparin-induced thrombocytopenia.

Authors:  Mohsen Sharifi; Curt Bay; Zoltan Vajo; Wilbur Freeman; Mirali Sharifi; Frederic Schwartz
Journal:  Thromb Res       Date:  2015-01-10       Impact factor: 3.944

3.  [Apixaban as therapeutic option in nephropathy patients with heparin-induced thrombocytopenia (HIT)].

Authors:  Guillermo Delgado-García; Roberto Monreal-Robles; Daniel Gallegos-Arguijo; Javier Marfil-Rivera
Journal:  Gac Med Mex       Date:  2015 Nov-Dec       Impact factor: 0.302

4.  Apixaban used for the management of heparin-induced thrombocytopenia in a 72-year-old woman with lung cancer.

Authors:  Pia Bükmann Larsen; Maja Jørgensen; Lennart Friis-Hansen; Steen Ingeberg
Journal:  Clin Case Rep       Date:  2015-10-29
  4 in total
  1 in total

1.  Apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement?

Authors:  Matej Samoš; Tomáš Bolek; Ingrid Škorňová; Jakub Benko; Ján Staško; Peter Kubisz; Peter Galajda; Marián Mokán
Journal:  J Thromb Thrombolysis       Date:  2019-11       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.